Antimicrobial Resistance: Biofilms and Infection Control | Part 1 | 感控 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字;遇到過度簡化或舊門檻,請搭配下方提示與原始資料閱讀。這是概念學習材料,不替代個別醫療評估。

Lyrics · 完整歌詞

Antimicrobial resistance emerges and spreads through genetic variation, gene transfer and selection,
rather than a purposeful response by individual organisms.
Every large bacterial population contains a few organisms carrying resistance genes,
which grow slowly under that burden.
A broad-spectrum antibiotic clears their susceptible neighbours and empties the niche,
so the resistant few inherit the whole space.
Hospitals breed resistant organisms because three conditions coincide: the highest antibiotic density,
the weakest hosts and the most invasive devices.
Reducing unnecessary selection pressure and interrupting transmission are therefore central to control,
alongside effective diagnostics, appropriate treatment and the development of new therapies.

Carbapenem-resistant Acinetobacter baumannii illustrates the mechanism.
It stacks an OXA-type carbapenemase,
loss of outer membrane porins and active efflux pumps,
so it usually resists almost every other class as well.
Moreover, it tolerates dryness and survives for weeks on bed rails,
keyboards and ventilator screens.
Environmental cleaning and contact precautions therefore matter as much as any antibiotic.
MRSA resists through an altered target, PBP2a encoded by mecA,
so beta-lactamase inhibitors achieve nothing.
Community strains carry Panton-Valentine leukocidin and cause abscesses
and necrotising pneumonia in the young.

Among carbapenem-resistant Enterobacterales, KPC is a serine enzyme, whereas NDM,
IMP and VIM are zinc-dependent metallo-beta-lactamases that clavulanate cannot inhibit.

Antimicrobial resistance emerges and spreads through genetic variation, gene transfer and selection,
rather than a purposeful response by individual organisms.


Antimicrobial stewardship asks four questions: the right drug, the right dose,
de-escalation and duration.
Prospective audit with feedback and pre-authorisation are its principal tools.
Healthcare-associated infection follows one structure, a device, a duration and a host.
Central line, catheter and ventilator each bypass a natural barrier,
and organisms ascending them lay down a biofilm.
Within that film metabolism slows,
antibiotics penetrate poorly and immune cells cannot enter,
so the cure is removal rather than escalation.
Every bundle ends with daily assessment of necessity,
and each infection is defined after more than two days of device exposure.

Central line insertion demands hand hygiene, maximal sterile barriers,
chlorhexidine skin preparation and avoidance of the femoral site,
with hub disinfection thereafter.
Urinary catheters are inserted only for clear indications,
drained in a closed system kept below the bladder
and never on the floor.
Ventilated patients are nursed at thirty to forty-five degrees with daily sedation interruption,
chlorhexidine mouth care and subglottic drainage.
Surgical prophylaxis is given within sixty minutes before incision,
hair is clipped rather than shaved, and glucose and temperature are controlled.

Hand hygiene has five moments arranged by causation.
Before touching a patient and before an aseptic procedure protect the patient.
After body fluid exposure,
after touching the patient
and after touching the surroundings protect the next patient and the worker.
Alcohol rub fails on soiled hands and after Clostridioides difficile.
Isolation is layered on standard precautions.
Contact applies to MRSA, Acinetobacter and difficile,
and droplet with surgical masks to influenza, pertussis and meningococcus.
Airborne isolation with negative pressure and N95 respirators is reserved for tuberculosis,
measles and varicella.
The 2003 SARS epidemic taught that isolation must separate rather than aggregate,
leaving behind fever screening, patient flow design and the TOCC history.

Antimicrobial resistance emerges and spreads through genetic variation, gene transfer and selection,
rather than a purposeful response by individual organisms.

Medical Notes · 醫學學習提示

  1. 抗藥性來自變異、基因轉移與選擇壓力
  2. 不是細菌有意識地決定抵抗藥物
  3. 大族群可能已有抗藥變異,不是每群都必然有
  4. 抗藥性的適存成本不一,也可能被補償
  5. 抗生素抑制敏感菌,改變族群競爭
  6. 抗藥菌可能因此增加,並非必然完全取代
  7. 醫院常有較高抗生素暴露與傳播機會
  8. 易感宿主與侵入器材也增加風險
  9. 減少不必要用藥,同時阻斷傳播
  10. 搭配有效診斷、合適治療與新療法
  11. CRAB 常有多種抗藥機轉;圖為通用生物膜
  12. OXA 型碳青黴烯酶是常見機轉之一
  13. 膜孔減少與外排幫浦可共同參與
  14. 常為多重抗藥,但仍須依藥敏選擇治療
  15. Acinetobacter 可在乾燥表面存活數週
  16. 高接觸表面清潔與器材處理都重要
  17. 環境清潔、接觸防護與合適治療並行
  18. MRSA 常由 mecA/PBP2a 改變藥物標的
  19. 一般酶抑制劑無法修復標的;仍有抗 MRSA 頭孢
  20. 部分社區株帶 PVL,並非所有菌株都有
  21. 可造成膿瘍或壞死性肺炎,不能只靠年齡判斷
  22. KPC 為絲胺酸酶;NDM 等屬金屬酶
  23. NDM/IMP/VIM 依賴鋅;clavulanate 無效
  24. 抗生素管理:適當藥物與劑量
  25. 依檢驗降階,選擇有效且適當的療程
  26. 前瞻稽核回饋與事前授權是核心策略
  27. 器材、留置時間與宿主風險共同影響感染
  28. 管路可突破天然屏障,須有明確適應症
  29. 微生物可附著並形成生物膜
  30. 膜內部分細菌代謝較慢,增加藥物耐受
  31. 穿透與免疫清除受影響,並非完全進不去
  32. 感染源控制很重要;是否拔管須依病原與病況
  33. 每日評估器材必要性,及早移除不需要者
  34. 監測常用 >2 個日曆天;並非單靠時間就算感染
  35. 置入中心導管:手部衛生與最大無菌屏障
  36. 適用者 CHG 皮膚消毒;成人盡量避免股靜脈
  37. 每次接觸接頭前,按規範消毒並待乾
  38. 導尿管僅用於明確適應症,避免不必要留置
  39. 保持密閉引流,尿袋低於膀胱
  40. 尿袋不可放地上,避免阻塞與逆流
  41. 無禁忌時床頭 30–45 度;每日評估鎮靜減量
  42. 更新:刷牙口腔照護,不常規用 CHG;引流依適應症
  43. 多數預防藥切皮前 60 分鐘;長輸注藥可提早至 120
  44. 需要除毛才剪毛不剃毛,並維持體溫與血糖
  45. 手部衛生五時機,嵌入每次照護流程
  46. 接觸病人前、清潔或無菌操作前
  47. 體液暴露風險後,移除手套也要手部衛生
  48. 接觸病人後
  49. 接觸周遭環境後,保護病人與工作人員
  50. 可見髒污用肥皂水;酒精不殺孢子,依感染管制指引
  51. 傳播途徑防護,加在標準防護之上
  52. MRSA、抗藥 Acinetobacter、CDI 常需接觸防護
  53. 流感、百日咳、腦膜炎雙球菌採飛沫防護
  54. TB 等需空氣隔離與合適呼吸防護;不只這三種
  55. 麻疹採空氣防護;水痘還須加接觸防護
  56. 分流與適當隔離很重要,同病原可依規範集中照護
  57. TOCC 與動線有助評估;不能只用發燒排除感染

References